Product Description
Acid/peptic disorders and motility disorders of the gastrointestinal tract are among the most common disorders affecting the general population. The Clinician's Guide to Acid/Peptic and Motility Disorders of the Gastrointestinal Tract is a practical guide that offers access to the advances made in recent years in acute treatment and maintenance therapy.
Drs. Henry Parkman and Robert Fisher have compiled a unique reference for the management of patients with these gastrointestinal disorders. Comprehensive and user-friendly, the topics covered in the treatment of acid/peptic disorders and motility disorders range from daily medication and on-demand regimens to gastric electrical stimulators. The Clinician's Guide to Acid/Peptic and Motility Disorders of the Gastrointestinal Tract will highlight clinical advances made in the care of patients, including a focus on symptoms, causes, evaluation, and treatment.
As part of The Clinician's Guide to GI Series , this text serves as a concise reference that allows clinicians to quickly access and evaluate the necessary information for treating and managing patients with acid/peptic and motility disorders.
Topics Include:
- Discussions of management of common acid-related GI problems, such as heartburn from GERD and abdominal pain from ulcer disease.
- Management of and new treatments for patients with classic motility disorders, such as achalasia and gastroparesis.
- Insight into the management of patients with functional GI disorders, such as functional dyspepsia and irritable bowel syndrome.
- A focus on the new promotility compounds and agents to treat irritable bowel syndrome, whether it be associated with predominant diarrhea or predominant constipation.
- The relationship of the bacterial population of the gastrointestinal tract to acid/peptic and motility disorders.
Including images, tables, and algorithms, The Clinician's Guide to Acid/Peptic and Motility Disorders of the Gastrointestinal Tract is the ideal reference for internists, gastroenterologists, surgeons, and oncologists looking to keep pace with the latest treatment options available today.
The Clinician's Guide to GI Series
The exciting new series, the Clinician's Guide to GI Series is the answer for which today's medical professionals who are managing patients with varying GI disorders have been waiting. As each patient will require a specific care plan, books that are concise, comprehensive and reader-friendly are priceless for the office.
Each specialized book included in the Clinician's Guide to GI Series provides the answer to establishing and managing the individualized care plan for each patient. Covering topics such as IBD, liver disease, and acid/peptic disorders, this essential series of books will allow the reader to quickly develop an individualized care plan based upon the recommendations of leading professionals in the field.
Written with a similar reader-friendly format and including images, tables, and algorithms, each book in the series will serve as a solid, go-to reference for the practicing gastroenterologist, fellow and medical student, as well as the internist and family practitioner.
Series Editor: Gary R. Lichtenstein, MD
top
Contents
Acknowledgments
About the Authors
Contributing Authors
Preface
Section I: Acid/Peptic Disorders
Chapter 1: | Gastroesophageal Reflux Disease
Presentations and Evaluations of Gastroesophageal Reflux Disease
Joel E. Richter, MD |
| Chapter 2: | Medical Treatment of Gastroesophageal Reflux Disease
Kevin S. Skole, MD and Robert S. Fisher, MD |
| Chapter 3: | Complications of Gastroesophageal Reflux Disease: Esophageal Stricture, Barrett’s Esophagus, and Esophageal Adenocarcinoma
Stuart J. Spechler, MD |
| Chapter 4: | Surgical Treatment of Gastroesophageal Reflux Disease
Daniel T. Dempsey, MD, FACS |
| Chapter 5: | Endoscopic Treatment of Gastroesophageal Reflux Disease
Annapurna Korimilli, MD; Mark Lee, BS; and Larry S. Miller, MD |
Chapter 6: | Peptic Ulcer Disease
Peptic Ulcer Disease
M. Michael Wolfe, MD; Jonathan T. Simon, MD; and Robert C. Lowe, MD |
| Chapter 7: | Complications of Peptic Ulcer Disease: Recognition, Management, Bleeding, Perforation, and Obstruction
Paul J. Bandini Jr, MD and Nikhil Deshpande, MD |
Section II: Motility Disorders Including Selected Functional Bowel Disorders
Chapter 8: | Esophagus
Oropharyngeal Dysphagia: Causes, Evaluation, and Treatment
Radu Tutuian, MD and Donald Castell. MD |
| Chapter 9: | Motility Disorders of the Esophagus
John G. Lieb II, MD and David A. Katzka, MD |
| Chapter 10: | Unexplained (Noncardiac) Chest Pain
Ronnie Fass, MD, FACP, FACG and Ram Dickman, MD |
Chapter 11: | Stomach
Gastroparesis: Presentation, Evaluation, and Management
Kashyap V. Panganamamula; Frank K. Friedenberg, MD; Robert S. Fisher, MD; and Henry P. Parkman, MD |
| Chapter 12: | Dumping Syndrome: A Clinician’s Guide
Gregg W. Van Citters, PhD and Henry C. Lin, MD |
| Chapter 13: | Functional Dyspepsia
Alex S. Kuryan, MD and Frank K. Friedenberg, MD |
| Chapter 14: | Nausea and Vomiting: Etiologies and Treatment
William L. Hasler, MD |
Chapter 15: | Small Bowel
Small Intestinal Dysmotility
Ann Ouyang, MB, BS and Ian Roy Schreibman, MD |
| Chapter 16: | Small Bowel Bacterial Overgrowth
Kathleen Lukaszewski, DO; Marianne T. Ritchie, MD; and Dilip Bearelly, MD |
Chapter 17: | Colon
Irritable Bowel Syndrome
Rupa N. Shah, MD and Brenda J. Horwitz, MD |
| Chapter 18: | Evaluation and Management of Constipation
Benjamin Krevsky, MD, MPH |
| Chapter 19: | Fecal Incontinence
Arnold Wald, MD |
| Chapter 20: | Intestinal Gas
Harvey Licht, MD |
Index
top
Review
"This is an excellent update and comprehensive review of clinical motility in today’s practice. . . The solid binding and simple layout make the book attractive and practical to use. . .The graphics and tables have been appropriately chosen, are a great complement to the information and serve as a quick review for each
topic. . .The format is succinct and to the point with appropriate references to back up the statements. . .This well written book should be a must reference text for people in the field and for practicing general gastroenterologists, fellows, residents and primary care physicians."
— Juan Carlos Garcia, MD, Practical Gastroenterology
top
About the Authors
Henry P. Parkman is Professor of Medicine in the Gastroenterology Section of the Department of Medicine at Temple University School of Medicine, Philadelphia, Pa.
Dr. Parkman’s gastroenterology training began with a gastrointestinal (GI) fellowship at the University of Pennsylvania. His research investigated the inhibitory neural circuitry of the lower esophageal sphincter (LES), the barrier preventing gastroesophageal reflux. At the University of Pennsylvania, he also compared the clinical outcomes and costs of pneumatic dilation and surgical esophagomyotomy for treatment of patients with achalasia, a disorder involving abnormal LES neural control. Dr. Parkman extended his research training with an NIH research training fellowship in the Department of Physiology at Mayo Clinic where he studied the neural reflexes governed by the inferior mesenteric ganglion.
Since joining the faculty of Temple University School of Medicine in 1990, Dr. Parkman has been actively involved in studying GI motility at both the basic science and clinical levels. His basic research has focused on gaining greater insights into excitation-contraction mechanisms for gastric and gallbladder muscle.
Dr. Parkman is Director of the Clinical GI Motility Laboratory at Temple University Hospital. He has developed expertise in a comprehensive array of GI motility tests for clinical evaluation of patients, including specialized tests of gastric motility. His clinical research studies have focused primarily on esophageal and gastric motility in normal individuals and on clinical motility disorders of the esophagus and stomach, primarily achalasia and gastroparesis. He is funded with an NIH K24 Midcareer Investigator Award in Patient-Oriented Research Award entitled “Novel Evaluation & Treatment of Gastric Dysmotility.” This grant allows him the time to perform research and mentor others.
Dr. Parkman holds several positions for Temple University, the School of Medicine, and the Department of Medicine, including Director of the Clinical Research Center, Medical Director of the Office of Clinical Research, Vice Chair of the Research Committee for the Department of Medicine, and Chair of the IRB Adverse Events Committee.
Dr. Parkman has been on the Council of the American Motility Society (AMS) for the last 6 years and has been President of the AMS for the last 2 years. The AMS is the national GI motility organization that seeks to foster excellence in research and medical practice in neurogastroenterology and GI motility. Dr. Parkman has been co-director of the highly successful biennial AMS Clinical Motility Courses.
Robert S. Fisher is Professor of Medicine and Chief of the Gastroenterology Section and Digestive Disease Center at Temple University School of Medicine. Dr. Fisher obtained an undergraduate degree in Engineering from Princeton University. He attended medical school at the University of Pennsylvania School of Medicine following which he completed a straight medical internship at the Chicago Wesley Memorial Hospital of Northwestern University Medical School.
Dr. Fisher spent a year studying medical applications of LASER energy at the United States Army Medical Research Laboratories in Fort Knox, Ken before serving 1 year in South Vietnam where he was awarded a Vietnamese Honor Medal by the South Vietnamese government and a Bronze Star by the U.S. Army. Dr. Fisher then completed a medical residency and chief residency at Temple University Hospital under the tutelage of Dr. Sol Sherry. He obtained training in gastroenterology at the Hospital of the University of Pennsylvania before returning to the Temple University School of Medicine in 1972. Dr. Fisher has been Chief of the Gastroenterology Section at Temple for 21 years.
Dr. Fisher’s research has spanned the GI tract. Early in his career, he published a series of studies defining the physiology of the pyloric sphincter and its abnormality in patients with gastric ulcer disease. This was followed by the development of a number of scintigraphic techniques to quantitate aboral and retrograde movement of luminal contents through the gastrointestinal tract. The techniques included esophageal transit, gastroesophageal reflux, gastric emptying, enterogastric reflux, small bowel transit, and colonic transit, as well as whole gut scintigraphy. Dr. Fisher was the first investigator to demonstrate decreased gallbladder emptying as a pathogenetic factor in the pathogenesis of cholesterol gallstones. This observation was followed by a series of studies on the physiology of gallbladder motility.
In more recent years, Dr. Fisher has focused on the distribution of acid in the upper gastrointestinal tract as it relates to gastroesophageal reflux disease and Barrett’s esophagus. Years ago, he opened the first multidisciplinary Functional Gastrointestinal Disease Center in the country. During his tenure, Dr. Fisher’s research has been funded by the NIH as well as a host of pharmaceutical companies.
Dr. Fisher has published more than 130 peer-reviewed articles, 130 invited chapters or reviews, and more than 150 abstracts.
top